Trump Administration Launches Major Crackdown on Misleading Pharmaceutical Ads
Trump Administration Launches Major Crackdown on Misleading Pharmaceutical Ads President Donald Trump signed a significant memorandum on Tuesday, September 9, 2025, initiating a broad effort to enforce transparency laws in pharmaceutical advertising, with a particular focus on social media platforms. This move, announced just days after Health and Human Services Secretary Robert Kennedy Jr. testified before the Senate Finance Committee on September 4, 2025, aims to ensure consumers receive accurate and transparent information about medications. The administration is poised to…